Global Amoxicillin Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Amoxicillin Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Amoxicillin Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 4.70 Billion
Diagram Market Size (Forecast Year)
USD 5.51 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Pfizer
  • AstraZeneca
  • BristolMyers Squibb
  • Dr. Reddy's Laboratories
  • Endo International

Global Amoxicillin Market, By Drug Class (Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides), Therapy Type (Monotherapy, Combinational Therapy), Indication (Respiratory Tract Infection, Skin Infection, Chest Infection, Ear Infection, Urinary Tract Infection, Bacterial Endocarditis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Amoxicillin Market

Amoxicillin Market Analysis and Size

The global amoxicillin market is expected to witness significant growth during the forecast period. The wide use of amoxicillin among primary care physicians has been growing for treating a wide spectrum of common infections, notably acute respiratory infections, dental abscesses, ear infections, and stomach ulcers. This is used in those who have kidney problems, it is not harmful for pregnant women and also during breastfeeding. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global amoxicillin market in the forecast period 2022-2029. The expected CAGR of global amoxicillin market is tend to be around 2% in the mentioned forecast period. The market was valued at USD 4.7 billion in 2021, and it would grow upto USD 5.51 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Amoxicillin commercialized under the brand name of Amoxil, Moxatag, and Larotid is a penicillin antibiotic widely used in treating respiratory tract infection. It acts as bactericidal as it hinders the cell wall biosynthesis of the bacteria. It is an antibiotic that is often used for the treatment of a number of bacterial infections. It may be used for skin infections, middle ear infection, strep throat, pneumonia, and urinary tract infections among others. It is mostly taken by mouth, or less commonly by injection.

Amoxicillin Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drug Class (Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides), Therapy Type (Monotherapy, Combinational Therapy), Indication (Respiratory Tract Infection, Skin Infection, Chest Infection, Ear Infection, Urinary Tract Infection, Bacterial Endocarditis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Lupin (India), Cipla Inc (India), Aurobindo Pharma (India), Zydus Group (India), Wockhardt (India)

Market Opportunities

  • Increased Investments
  • Increasing Demand for Retail Pharmacies

Global Amoxicillin Market Dynamics

Drivers

  • Increased Understanding of Antibiotics

The rising understanding of the common harms of antibiotics is a primary trend that is shaping the contours of demand in the amoxicillin market. Several pharmaceutical companies have gained from the increasing array of the approved indications by the U.S. FDA for amoxicillin. Some of them are Helicobacter pylori eradication, ear, nose, and throat infections, lower respiratory tract infections, and acute bacterial sinusitis. Thus, it boosts the market growth.

  • Higher Pace of Research Activities and Developments

Amoxicillin has proven to be safe in use in pregnant women and nursing mothers. Regulatory agencies are inclined to update the guidelines eventually in the light of emerging evidence. Some of the common ones are hypersensitivity reactions, nephrotoxicity,  and hepatotoxicity. Several ongoing studies on postmarketing adverse drug reactions are expected to shape the future growth courses of the amoxicillin market.

Opportunities

  • Growing Impaired Renal Function

The increasing patients with impaired renal function is a main trend strengthening the opportuities in the amoxicillin market. The rapidly aging population in highly developing countries is boosting market expansion growth. The rising occurrence of urinary tract infections among women is also creating expansion for the amoxicillin market expansion.

  • Prevalence of Lower Respiratory Infections

Lower respiratory tract infections have encouraged the demand for products in the amoxicillin market. In community-acquired pneumonia, it is widely used in combination of macrolide. Skin infections that is caused due to Streptococcus species, Staphylococcus species, and Escherichia coli boosts a substantial avenue.

 Restraints/Challenges

  • Side Effects of Amoxicillin

There are several adverse effects that are related with amoxicillins that hamper the growth of the market. Effect such as black, tarry stools, bloody nose, chest pain, back, leg, or stomach pains, bloating, blood in the urine hamper the market growth.

  • High Cost

The huge expenditure associated with the production and development phases of these amoxicillins surely hamper the market growth.

  • Lack of Proper Medication

Lack of appropriate medications and treatment is expected to increase this medical condition's effects. According to the market analysis, less awareness can lead to a small adoption rate of amoxicillin. Thus, these factors can restrict the total demand for the olanzapine market during the forecast period.

This global amoxicillin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global amoxicillin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Amoxicillin Market

The huge infection rate and severe impact on public health systems has led numerous governments to reinforce nationwide lockdowns considerably impacting manufacturing supply chains, trade, and related services. The global impact of COVID-19 significantly affected the Amoxicillin market in 2020. The outbreak of COVID-19 led to travel bans and quarantines; uncertainty in the stock market; falling business confidence, and rising panic among the population. Despite the rising uncertainty and panic, technology suppliers should continue to focus on their long-term investments, maintain engagement with partners and prospects, and look to specific markets for stability.

Global Amoxicillin Market Scope

The global amoxicillin market is segmented on the basis of therapy type, indication, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

  • Penicillin
  • Cephalosporin
  • Tetracycline
  • Macrolides
  • Sulfonamides

Therapy Type

  • Monotherapy
  • Combinational Therapy

Indication

  • Respiratory Tract Infection
  • Skin Infection
  • Chest Infection
  • Ear Infection
  • Urinary Tract Infection
  • Bacterial Endocarditis
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Amoxicillin Market Regional Analysis/Insights

The global amoxicillin market is analysed and market size insights and trends are provided by therapy type, indication, distribution channel and end-user as referenced above.

The major countries covered in the global amoxicillin market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing the highest growth for the global amoxicillin market throughout the forecasted period due to the increase’s cases of cardiovascular diseases and rapidly aging population.

North America dominates the market due to the increase prevalence of respiratory infections and advanced healthcare facilities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Amoxicillin Market Share Analysis

The global amoxicillin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global amoxicillin market.

Key players operating in the global amoxicillin market include:

  • Pfizer Inc (U.S.)
  • AstraZeneca (U.K.)
  • Bristol-Myers Squibb Company (U.S.)
  • Dr. Reddy's Laboratories Ltd (India)
  • Endo International plc (Ireland)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sun Pharmaceutical Industries Ltd (India)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Lupin (India)
  • Cipla Inc (India)
  • Aurobindo Pharma (India)
  • Zydus Group (India)
  • Wockhardt (India)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Drug Class (Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides), Therapy Type (Monotherapy, Combinational Therapy), Indication (Respiratory Tract Infection, Skin Infection, Chest Infection, Ear Infection, Urinary Tract Infection, Bacterial Endocarditis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029. .
The Global Amoxicillin Market size was valued at USD 4.70 USD Billion in 2021.
The Global Amoxicillin Market is projected to grow at a CAGR of 2% during the forecast period of 2022 to 2029.
The major players operating in the market include Pfizer, AstraZeneca, BristolMyers Squibb, Dr. Reddy's Laboratories, Endo International, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Mylan, Novartis, Lupin, Cipla, Aurobindo Pharma, Zydus Group, Wockhardt.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.